ZI-H04-A novel MHC class II restricted TCR based cellular therapy targeting hTERT to treat solid tumours

Marschner, JP; Welschof, M; Forte, M; Klemsdal, EK; Pollmann, S; Zelluna, NH

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019; 7 ():